JP2016512250A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016512250A5 JP2016512250A5 JP2016500489A JP2016500489A JP2016512250A5 JP 2016512250 A5 JP2016512250 A5 JP 2016512250A5 JP 2016500489 A JP2016500489 A JP 2016500489A JP 2016500489 A JP2016500489 A JP 2016500489A JP 2016512250 A5 JP2016512250 A5 JP 2016512250A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical formulation
- hours
- particles
- particle size
- sulfonic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/832,694 US20140271892A1 (en) | 2013-03-15 | 2013-03-15 | Phenylephrine resinate particles having good auc |
| US13/832,694 | 2013-03-15 | ||
| PCT/US2014/019301 WO2014149526A1 (en) | 2013-03-15 | 2014-02-28 | Phenylephrine resinate particles |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016512250A JP2016512250A (ja) | 2016-04-25 |
| JP2016512250A5 true JP2016512250A5 (enExample) | 2017-03-09 |
| JP6314206B2 JP6314206B2 (ja) | 2018-04-18 |
Family
ID=50272778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016500489A Expired - Fee Related JP6314206B2 (ja) | 2013-03-15 | 2014-02-28 | 樹脂酸フェニレフリン粒子 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20140271892A1 (enExample) |
| EP (1) | EP2968223B1 (enExample) |
| JP (1) | JP6314206B2 (enExample) |
| CN (2) | CN105263483A (enExample) |
| AU (1) | AU2014238059B2 (enExample) |
| BR (1) | BR112015022975B1 (enExample) |
| CA (1) | CA2906357C (enExample) |
| IL (1) | IL241050B (enExample) |
| MX (1) | MX383890B (enExample) |
| PH (1) | PH12015502066A1 (enExample) |
| RU (1) | RU2675788C2 (enExample) |
| UA (1) | UA116372C2 (enExample) |
| WO (1) | WO2014149526A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA41152A (fr) | 2014-12-12 | 2017-10-17 | Johnson & Johnson Consumer Inc | Procédé de fabrication de particules de résinate de phényléphrine ; particules de résinate de phényléphrine et utilisation des particules de résinate de phényléphrine dans des formulations pharmaceutiques |
| CN109187832B (zh) * | 2018-09-30 | 2021-07-30 | 华润三九医药股份有限公司 | Lc-ms/ms测定去氧肾上腺素浓度的方法及样品的前处理方法 |
| KR20230127266A (ko) * | 2020-12-29 | 2023-08-31 | 애브비 인코포레이티드 | 서방형 우파다시티닙 제형 |
| US12303604B1 (en) | 2024-10-16 | 2025-05-20 | Currax Pharmaceuticals Llc | Pharmaceutical formulations comprising naltrexone and/or bupropion |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH693625A5 (it) * | 1999-02-18 | 2003-11-28 | Inpharma Sa | Composizioni farmaceutiche contenenti composti ad attività promotrice di assorbimento di principi attivi. |
| WO2003020242A1 (en) * | 2001-08-29 | 2003-03-13 | Srl Technologies, Inc. | Sustained release preparations |
| US20040265373A1 (en) * | 2003-06-27 | 2004-12-30 | David Wynn | Soft tablet containing high molecular weight cellulosics |
| US20050266032A1 (en) * | 2003-12-17 | 2005-12-01 | Sovereign Pharmaceuticals, Ltd. | Dosage form containing multiple drugs |
| US9492541B2 (en) * | 2004-09-14 | 2016-11-15 | Sovereign Pharmaceuticals, Llc | Phenylepherine containing dosage form |
| US20050265955A1 (en) * | 2004-05-28 | 2005-12-01 | Mallinckrodt Inc. | Sustained release preparations |
| KR101495146B1 (ko) * | 2006-03-16 | 2015-02-24 | 트리스 파마 인코포레이티드 | 약물 - 이온교환 수지 복합체를 함유하는 변형 방출 제제 |
| US20080064694A1 (en) * | 2006-09-11 | 2008-03-13 | Auriga Laboratories, Inc. | Multi-Phase Release Methscopolamine Compositions |
| JP2010510320A (ja) * | 2006-11-21 | 2010-04-02 | マクニール−ピーピーシー・インコーポレーテツド | 改変型放出鎮痛性懸濁液 |
| US8323695B2 (en) * | 2007-08-13 | 2012-12-04 | Mcneil-Ppc, Inc. | Method for stabilizing phenylephrine |
| CN102119027A (zh) * | 2008-06-26 | 2011-07-06 | 麦克内尔-Ppc股份有限公司 | 含有药物活性剂的包衣颗粒 |
| WO2010115015A1 (en) * | 2009-04-03 | 2010-10-07 | Coating Place, Inc. | Modified-release pharmaceutical drug composition |
| US20130230587A1 (en) * | 2010-11-10 | 2013-09-05 | Rubicon Research Private Limited | Sustained release compositions |
-
2013
- 2013-03-15 US US13/832,694 patent/US20140271892A1/en not_active Abandoned
-
2014
- 2014-02-28 CA CA2906357A patent/CA2906357C/en active Active
- 2014-02-28 EP EP14709863.6A patent/EP2968223B1/en active Active
- 2014-02-28 UA UAA201509684A patent/UA116372C2/uk unknown
- 2014-02-28 CN CN201480015698.2A patent/CN105263483A/zh active Pending
- 2014-02-28 MX MX2015012340A patent/MX383890B/es unknown
- 2014-02-28 BR BR112015022975-1A patent/BR112015022975B1/pt not_active IP Right Cessation
- 2014-02-28 JP JP2016500489A patent/JP6314206B2/ja not_active Expired - Fee Related
- 2014-02-28 AU AU2014238059A patent/AU2014238059B2/en not_active Ceased
- 2014-02-28 CN CN202010471359.2A patent/CN111658624A/zh active Pending
- 2014-02-28 WO PCT/US2014/019301 patent/WO2014149526A1/en not_active Ceased
- 2014-02-28 RU RU2015144181A patent/RU2675788C2/ru active
-
2015
- 2015-09-02 IL IL241050A patent/IL241050B/en active IP Right Grant
- 2015-09-11 PH PH12015502066A patent/PH12015502066A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7019727B2 (ja) | インフルエンザの治療方法 | |
| Li et al. | Inhibition of H1N1 influenza virus-induced apoptosis by functionalized selenium nanoparticles with amantadine through ROS-mediated AKT signaling pathways | |
| Li et al. | Silver nanoparticle based codelivery of oseltamivir to inhibit the activity of the H1N1 influenza virus through ROS-mediated signaling pathways | |
| Pourshahab et al. | Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid | |
| Li et al. | Inhibition of H1N1 influenza virus-induced apoptosis by selenium nanoparticles functionalized with arbidol through ROS-mediated signaling pathways | |
| Wang et al. | Antiviral activity of puerarin as potent inhibitor of influenza virus neuraminidase | |
| JP2012503668A5 (enExample) | ||
| JP2014528474A5 (enExample) | ||
| JP2016512250A5 (enExample) | ||
| JP2016518388A5 (enExample) | ||
| JP2010515682A5 (enExample) | ||
| BRPI0906851B1 (pt) | Formulação em aerossol com sais de aminoácidos básicos de ácido acetilsalicílico e uso de sais de aminoácidos básicos de ácido acetilsalicílico no tratamento de infecções virais | |
| JP2015515968A5 (enExample) | ||
| CN104288170B (zh) | 松果菊苷在抗肿瘤药物中的应用 | |
| RU2015144181A (ru) | Частицы резината фенилэфрина | |
| Mokra et al. | N-Acetylcysteine in the Treatment of Acute Lung Injury: Perspectives and Limitations | |
| JP2011500731A5 (enExample) | ||
| CN103705537A (zh) | 硫化氢及其供体硫氢化钠在制备治疗脂质代谢紊乱药物中的用途 | |
| MX373699B (es) | Composicion farmaceutica que contiene budesonida y formoterol. | |
| CN102772398A (zh) | 二氢杨梅素在制备防治流感药物中的应用 | |
| CN102670532B (zh) | 伊潘立酮药物组合物及其制备方法 | |
| CN103341026B (zh) | 一种防治流感的组合物及其制剂制备方法和应用 | |
| CN103239401B (zh) | 一种非诺贝特纳米混悬剂及其制备方法 | |
| CN104739761A (zh) | 一种盐酸氨溴索毫微粒的制备方法 | |
| WO2018201920A1 (zh) | 龙虎人丹在制备预防和/或治疗肝纤维化药物中的应用 |